FMP
PAVmed Inc
PAVMZ
NASDAQ
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
0.0094 USD
-0.0001 (-1.06%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Dr. Lishan Aklog M.D.
sector
Healthcare
industry
Medical - Devices
website
https://www.pavmed.comexchange
NASDAQ
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc....
CIK
0001624326
ISIN
US70387R1225
CUSIP
70387R122
Address
360 Madison Avenue
Phone
212 949 4319
Country
US
Employee
107
IPO Date
Apr 10, 2018
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
PAVMZ Financial Summary
CIK
0001624326
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
70387R122
ISIN
US70387R1225
Country
US
Price
0.01
Beta
0.69
Volume Avg.
0
Market Cap
7.14M
Shares
-
52-Week
0.0094-0.0094
DCF
-0.01
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-
P/B
-
Website
https://www.pavmed.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PAVMZ News
It looks like there's no news available.
